Predictors of Survival of DKD Patients in Assiut University Hospital
NCT ID: NCT06865456
Last Updated: 2025-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
129 participants
OBSERVATIONAL
2025-05-01
2026-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Diabetes is associated with multiple complications that can significantly impact patient outcomes . In 2019 alone, around 4.2 million deaths were attributed to diabetes and its complications, accounting for approximately 11.3% of all global deaths .
In diabetic patients, several factors influence renal survival, including glycemic control, blood pressure management, lifestyle interventions, and pharmacological therapies such as renin-angiotensin-aldosterone system (RAAS) inhibitors, sodium-glucose co-transporter-2 (SGLT2) inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists(9). Early detection of kidney dysfunction through biomarkers like estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR) plays a pivotal role in improving renal outcomes.
This study aims to evaluate the factors affecting Patients survival in diabetic patients, identify early predictors of renal function decline, and assess the effectiveness of current therapeutic strategies.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Chronic Kidney Disease Among Type 2 Diabetic Patients in Assiut University Hospitals
NCT05847400
Development of Early Diagnostic Techniques and Setup of Local Therapeutic Guidelines and Standards
NCT00912704
Dcr3 Levels in Blood and Urine on Renal and Patient Prognosis in Patients With Acute Kidney Injury
NCT05735093
Population-based Chronic Kidney Disease Cohort at Northern Taiwan
NCT03004898
Normoalbuminuric Chronic Kidney Disease in Type 2 Diabetes
NCT04411342
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
diapetic patient with diabetic nephropathy stage 4,5
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both sex
* diabetic patients with HbA1c level \>6.5( Type 1 and 2)
* Diabetic patients with CKD 4, 5 )
* HD Pt
Exclusion Criteria
* Acute kidney injury.
* Patients with any other causes of CKD autoimmune disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hasnaa Osama Hassan Reiad
residant doctor at Assiut university hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DKD predictors
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.